Back to Directory
Apelin-13
Performance & EnduranceEndogenous peptide with cardioprotective and metabolic effects, under research for heart failure.
Key Benefits
- ✓Improves cardiac output
- ✓Vasodilation
- ✓Enhances glucose metabolism
- ✓Cardioprotective effects
- ✓May improve insulin sensitivity
- ✓Potential for heart failure
Dosing Information
Dosage Range
Research stage
Frequency
Under investigation
Typical Duration
Investigational
Detailed Protocol
Research and investigational use. In studies, administered via intravenous or subcutaneous injection. Dosing protocols being established.
About Apelin-13
Apelin-13 is the most potent isoform of apelin, an endogenous peptide ligand for the APJ receptor. It has positive inotropic effects, promotes vasodilation, and improves glucose metabolism. Being studied for heart failure and metabolic diseases.
Research Notes
Research shows promising cardiovascular and metabolic effects. Clinical trials exploring use in heart failure and metabolic syndrome. Development ongoing.
Potential Side Effects
- •Generally well tolerated in studies
- •Limited human data
Always consult with a healthcare professional before starting any peptide therapy.